Gordon Wilks, DPM
Podiatrist · Roseburg, ORNPI 1316006539
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $709 of the $802 with a category attached, or 88.4%. 11 manufacturers reported payments, led by Amgen at 26.3% of the total. That places this record below the midpoint for podiatrist clinicians in OR, where the typical reported total is $1,169.
Across 22 payments — averaging $36.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$211
- GRT US Holding, Inc.$171
- Vaporox, Inc.$159
- Rikco International, LLC$93
- KCI USA, Inc.$61
- Paratek Pharmaceuticals, Inc.$23
- plus $84 from 5 others
What the payments were for
- Food & beverage$70988%
- Education$9312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 6 | $211 |
| GRT US Holding, Inc. | 3 | $171 |
| Vaporox, Inc. | 2 | $159 |
| Rikco International, LLC | 2 | $93 |
| KCI USA, Inc. | 1 | $61 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Smith+Nephew | 1 | $21 |
| Biowound Solutions, Inc. | 3 | $18 |
| Vertex | 1 | $16 |
| DJO, LLC | 1 | $15 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$802 in reported general payments places this provider in the 40th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 30 | $797 |
| Duloxetine Hcl | 24 | $796 |
| Gabapentin | 105 | $683 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $527 |
| Colchicine | 17 | $329 |
| Allopurinol | 27 | $281 |
| Nortriptyline Hcl | 36 | $245 |
| Fluconazole | 11 | $138 |
| Mupirocin | 11 | $97 |
| Meloxicam | 56 | $93 |
| Cephalexin | 18 | $71 |
| Prednisone | 11 | $44 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Roseburg
- Nathaniel KeplingerRoseburg$2K
- Rick McClureMedford$133K
- Cyaandi DoveGrand Ronde$51K
- Stephen SchroederTigard$28K
- Colin MizuoHillsboro$18K
- Melinda NicholesPortland$15K
- Amanda KameryEugene$9K
- Peter PhamBeaverton$8K
- Liang-Chieh KoEugene$7K
- Kyle VillaruzGrants Pass$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.